Phase II trial of bevacizumab and irinotecan in the treatment of malignant gliomas
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Duke Medical Center
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2244332036
